Skip to content
Catalyst

PapersPMID:34227198

Effect of flaxseed consumption on central obesity, serum lipids, and adiponectin level in overweight or obese women: A randomised controlled clinical trial.

International journal of clinical practice2021The record ↗

findings
3
compound
1
endpoints
3
PMID:34227198
  1. Finding, very limited evidencelowersWaist circumference
  2. Finding, very limited evidencelowersWaist-to-hip ratio
  3. Finding, very limited evidenceraisesSerum adiponectin
Study, every finding
RCT · 3 months
Dose studied, every finding
30 g/day milled flaxseed for 12 weeks
Population, every finding
overweight or obese women; balanced diet plus 30 g/day milled flaxseed versus balanced diet plus 30 g/day milled rice
  • “After 12 weeks of intervention, there was significantly higher reduction rate in waist circumference (WC) and waist-to-hip ratio (WHR) (both P < .05) in the flaxseed-consuming group compared with the control group.”
  • “Moreover, adiponectin level was significantly increased from (12.11 ± 7.1) to (17.15 ± 6.1) in the flaxseed-consuming group compared with the control group from (12.48 ± 4.7) to (12.01 ± 5.8) (P = .002).”

Study record

Design
randomised controlled trial
Species
human
Population
overweight or obese women
Participants
60
Comparator
an active treatment / placebo
Duration
84 days
Endpoints measured
4